BioHealth News

Frederick’s Theradaptive Receives 2024 Best Technology in Spine Award by Orthopedics This Week

Frederick’s Theradaptive Receives 2024 Best Technology in Spine Award by Orthopedics This Week

FREDERICK, Md., Oct. 23, 2024 /PRNewswire/ -- Theradaptive, a privately held, clinical stage biologics company developing protein therapeutics for spine, orthopedics, soft tissue repair and targeted…

Read More
United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service

United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service

SILVER SPRING, Md. & JACKSONVILLE, Fla.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, and its subsidiary Lung Bioengineering Inc. (LBE) announced that the…

Read More
TDR: BioHealth Capital Region Forum: A recap of innovation and collaboration

TDR: BioHealth Capital Region Forum: A recap of innovation and collaboration

By: Tammi Thomas, Chief Development and Marketing Officer, TEDCO The 2024 BioHealth Capital Region Forum (BHCRF) once again solidified its position as the premier…

Read More
MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

ROCKVILLE, Md. & DEERFIELD, Ill.--(BUSINESS WIRE)--Oct. 22, 2024-- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment…

Read More
USP Acquires Stratix Labs, Enhancing Its Microbiology Portfolio with Innovative Technology

USP Acquires Stratix Labs, Enhancing Its Microbiology Portfolio with Innovative Technology

ROCKVILLE, MD - October 21, 2024 – Today, the U.S. Pharmacopeia (USP) announced the acquisition of Stratix Labs, a microbiology technology company based in Saint Paul,…

Read More
BioBuzz: Advancing Pediatric Medical Countermeasures Through the Newly BARDA-Funded Accelerator, SPARK for Innovations in Pediatrics

BioBuzz: Advancing Pediatric Medical Countermeasures Through the Newly BARDA-Funded Accelerator, SPARK for Innovations in Pediatrics

This article originally appeared in the Association for the Advancement of Medical Instrumentation’s (AAMI) new Insights into Innovation series is authored by Kolaleh Eskandanian, Ph.D., M.B.A., P.M.P., vice president…

Read More
Revolutionizing Global Drug Manufacturing with Dr. Frank Gupton of Phlow and Medicines for All on BioTalk

Revolutionizing Global Drug Manufacturing with Dr. Frank Gupton of Phlow and Medicines for All on BioTalk

In this episode of BioTalk, Rich Bendis speaks with Dr. Frank Gupton, Co-Founder of Phlow and CEO of the Medicines for All Institute, about…

Read More
REGENXBIO Shares Positive Phase II Data on Wet AMD Treatment at AAO 2024

REGENXBIO Shares Positive Phase II Data on Wet AMD Treatment at AAO 2024

ROCKVILLE, Md., Oct. 21, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced positive data from the Phase II fellow eye sub-study evaluating the subretinal delivery of…

Read More
Technical.ly: New life sciences building is the latest step in Jane Shaab’s mission to make Baltimore embrace itself

Technical.ly: New life sciences building is the latest step in Jane Shaab’s mission to make Baltimore embrace itself

This is How I Got Here, a series where we chart the career journeys of technologists. Want to tell your story? Get in touch. Baltimore’s reputation…

Read More
Supernus Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with Major Depressive Disorder

Supernus Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with Major Depressive Disorder

ROCKVILLE, Md., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the…

Read More
BIO Investor Forum opens with encouraging news on financing

BIO Investor Forum opens with encouraging news on financing

The tide has been rising in biotech investment in 2024—though it has not lifted all boats equally. While the volume of investment improved in…

Read More
Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting

Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting

Company continues to expect to hold an End-of-Phase 2 meeting with the FDA by year-endGAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics,…

Read More
BrainScope Completes Proof-of-Concept for Groundbreaking Early Alzheimer’s Prediction Biomarker

BrainScope Completes Proof-of-Concept for Groundbreaking Early Alzheimer’s Prediction Biomarker

ROCKVILLE, Md.--(BUSINESS WIRE)--BrainScope, a leader in brain diagnostics, today announced the successful completion of the proof-of-concept phase for a novel brain activity-based biomarker for…

Read More
Winners announced in $300,000 pediatric medical device competition focused on pediatric cardiology

Winners announced in $300,000 pediatric medical device competition focused on pediatric cardiology

WASHINGTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Six medical technology innovators focused on pediatric cardiology were selected to receive grants of $50,000 each in…

Read More
VEDP: University Partnerships Accelerate Innovation in Albemarle County, VA

VEDP: University Partnerships Accelerate Innovation in Albemarle County, VA

Federal agencies, defense contractors spur growth at Rivanna Station, North Fork Discovery ParkOn 462 acres in Albemarle County, a plot of land along U.S.…

Read More